Camp4 Therapeutics Corp (CAMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 64,039 | 2,528 | 0 | 0 | N/A |
| Receivables | N/A | 1,000 | 0 | 0 | N/A |
| TOTAL | $66,383 | $5,504 | $0 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 3,858 | 3,831 | N/A | N/A | N/A |
| Investments And Advances | 0 | 602 | 0 | 0 | 0 |
| Other Non-Current Assets | 8,066 | 11,427 | 0 | 0 | 0 |
| TOTAL | $11,924 | $15,860 | $N/A | $N/A | $N/A |
| Total Assets | $78,307 | $21,364 | $0 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,210 | 3,873 | 0 | 0 | 0 |
| Accrued Expenses | 4,833 | 3,677 | 0 | 0 | N/A |
| Other current liabilities | N/A | 190 | 0 | 0 | N/A |
| TOTAL | $9,598 | $11,829 | $0 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | 385 | 1,000 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 5,565 | 6,276 | 0 | 0 | 0 |
| TOTAL | $5,565 | $6,363 | $N/A | $N/A | $N/A |
| Total Liabilities | $15,163 | $18,192 | $0 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,161 | 20,161 | N/A | N/A | N/A |
| Common Shares | 2 | 2 | 0 | 0 | N/A |
| Retained earnings | -211,753 | -198,474 | 0 | 0 | N/A |
| TOTAL | $63,144 | $3,172 | $0 | $0 | $N/A |
| Total Liabilities And Equity | $78,307 | $21,364 | $0 | $0 | $0 |